MDxHealth EBIT per Share
The EBIT per Share of MDxHealth (MDXH) as of Oct 15, 2026 is -0.46 USD. In the previous year, EBIT per Share was -0.62 USD — a change of -24.56% (higher).
Get this data via API
Financial Data API
EBIT per Share
-0.46USD
YoY
-24.56%
Last updated:
The MDxHealth EBIT per Share history
3 Years
10 Years
25 Years
Max
| YEAR | EBIT per Share | YoY |
|---|---|---|
| est | 0.18USD | -260.10% |
| est | -0.11USD | +1.43% |
| est | -0.11USD | -66.47% |
| est | -0.34USD | -27.58% |
| -0.46USD | -24.56% | |
| -0.62USD | -47.38% | |
| -1.17USD | -65.48% | |
| -3.39USD | +52.25% | |
| -2.22USD | -26.50% | |
| -3.03USD | -53.54% | |
| -6.52USD | +20.26% | |
| -5.42USD | +117.89% | |
| -2.49USD | -9.26% | |
| -2.74USD | -26.55% | |
| -3.73USD | -14.25% | |
| -4.35USD | -30.09% | |
| -6.22USD | +16.60% | |
| -5.34USD | -0.17% | |
| -5.35USD | -36.65% | |
| -8.44USD | -47.31% | |
| -16.01USD | +20.26% | |
| -13.32USD | -10.05% | |
| -14.80USD | +22.71% | |
| -12.06USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
MDxHealth Stock analysis
Frequently Asked Questions about MDxHealth stock
EBIT per Share of MDxHealth is -0.46 USD in 2025.
EBIT per Share of MDxHealth changed from -0.62 USD to -0.46 USD, representing a -24.56% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share MDxHealth since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — MDxHealth
All Key Metrics — MDxHealth
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth